+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LightDeck Diagnostics Inc - Product Pipeline Analysis, 2024 Update

  • PDF Icon

    Company Profile

  • 38 Pages
  • August 2024
  • GlobalData
  • ID: 5457486
LightDeck Diagnostics Inc (LightDeck) is a subsidiary of Heska Corp, is a medical device company that offers clinical diagnostics and sample testing solutions. The company's product portfolio include COVID-19 antigen, COVID-19 antibody, hormones, host-response, cardiac markers, veterinary diagnostics and water testing. It operates biosafety laboratories in Boulder for biological assay development, method development and validation. The company utilizes planar waveguide technology platform. LightDeck is headquartered in Boulder, Colorado, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company LightDeck Diagnostics Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

  • LightDeck Diagnostics Inc Company Overview
  • LightDeck Diagnostics Inc Company Snapshot
  • LightDeck Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • LightDeck Diagnostics Inc - Pipeline Analysis Overview
  • LightDeck Diagnostics Inc - Key Facts
  • LightDeck Diagnostics Inc - Major Products and Services
  • LightDeck Diagnostics Inc Pipeline Products by Development Stage
  • LightDeck Diagnostics Inc Pipeline Products Overview
  • 5- PLex PERSEVERE Assay
  • 5- PLex PERSEVERE Assay Product Overview
  • Blood Transfer Device
  • Blood Transfer Device Product Overview
  • Diagnostic Test - Flu
  • Diagnostic Test - Flu Product Overview
  • LightDeck - Cardiac Markers
  • LightDeck - Cardiac Markers Product Overview
  • LightDeck - Sepsis
  • LightDeck - Sepsis Product Overview
  • LightDeck COVID-19 Rapid Antigen Test
  • LightDeck COVID-19 Rapid Antigen Test Product Overview
  • LightDeck COVID-19 Total Antibody Test
  • LightDeck COVID-19 Total Antibody Test Product Overview
  • LightDeck Inflammation Panel
  • LightDeck Inflammation Panel Product Overview
  • MBio Array System
  • MBio Array System Product Overview
  • mBio Diagnostic Assay - Tuberculosis
  • mBio Diagnostic Assay - Tuberculosis Product Overview
  • Multi-Marker Blood Test - Radiation Exposure
  • Multi-Marker Blood Test - Radiation Exposure Product Overview
  • POC Diagnostic Device - Malaria
  • POC Diagnostic Device - Malaria Product Overview
  • Point of Care Device - HIV
  • Point of Care Device - HIV Product Overview
  • Rapid Assay - Chest Pain Assessment
  • Rapid Assay - Chest Pain Assessment Product Overview
  • Rapid Diagnostic Test - Anthrax
  • Rapid Diagnostic Test - Anthrax Product Overview
  • LightDeck Diagnostics Inc - Key Competitors
  • LightDeck Diagnostics Inc - Key Employees
  • LightDeck Diagnostics Inc - Locations And Subsidiaries
  • Head Office
  • Recent Developments
  • LightDeck Diagnostics Inc, Recent Developments
  • Jan 26, 2022: LightDeck Diagnostics and The Henry M. Jackson Foundation for the Advancement of Military Medicine receive $2M to develop rapid, multiplexed inflammation test
  • Jul 08, 2021: DOD, HHS awards a $35.1M contract to LightDeck Diagnostics to increase production of its 5-Minute point-of-care tests for COVID-19
  • Feb 21, 2021: LightDeck Diagnostics awarded $5.65 million from BARDA to develop a rapid antigen test for SARS-CoV-2
  • Nov 20, 2020: LightDeck Diagnostics earns certification to ISO 13485:2016 / MDSAP, affirming excellence in company’s quality management system
  • Jun 23, 2020: MBio Diagnostics and BARDA partner on a 5-minute, Quantitative Point-of-Care COVID-19 Antibody Panel
  • Jun 15, 2020: MBio delivers rapid cytokine test system for COVID-19 research
  • Apr 06, 2020: MBio to seek FDA approval for LightDeck platform
  • Jan 26, 2020: Brava Diagnostics to present at Rockies Venture Club Demo Day
  • Jan 14, 2020: MBio Diagnostics announces new contracts with SRI
  • Nov 21, 2019: Brava Diagnostics awarded advanced industries grant from The State Of Colorado
  • Appendix
  • Methodology
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • LightDeck Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
  • LightDeck Diagnostics Inc Pipeline Products by Equipment Type
  • LightDeck Diagnostics Inc Pipeline Products by Indication
  • LightDeck Diagnostics Inc, Key Facts
  • LightDeck Diagnostics Inc, Major Products and Services
  • LightDeck Diagnostics Inc Number of Pipeline Products by Development Stage
  • LightDeck Diagnostics Inc Pipeline Products Summary by Development Stage
  • 5- PLex PERSEVERE Assay - Product Status
  • 5- PLex PERSEVERE Assay - Product Description
  • Blood Transfer Device - Product Status
  • Blood Transfer Device - Product Description
  • Diagnostic Test - Flu - Product Status
  • Diagnostic Test - Flu - Product Description
  • LightDeck - Cardiac Markers - Product Status
  • LightDeck - Cardiac Markers - Product Description
  • LightDeck - Sepsis - Product Status
  • LightDeck - Sepsis - Product Description
  • LightDeck COVID-19 Rapid Antigen Test - Product Status
  • LightDeck COVID-19 Rapid Antigen Test - Product Description
  • LightDeck COVID-19 Total Antibody Test - Product Status
  • LightDeck COVID-19 Total Antibody Test - Product Description
  • LightDeck Inflammation Panel - Product Status
  • LightDeck Inflammation Panel - Product Description
  • MBio Array System - Product Status
  • MBio Array System - Product Description
  • mBio Diagnostic Assay - Tuberculosis - Product Status
  • mBio Diagnostic Assay - Tuberculosis - Product Description
  • Multi-Marker Blood Test - Radiation Exposure - Product Status
  • Multi-Marker Blood Test - Radiation Exposure - Product Description
  • POC Diagnostic Device - Malaria - Product Status
  • POC Diagnostic Device - Malaria - Product Description
  • Point of Care Device - HIV - Product Status
  • Point of Care Device - HIV - Product Description
  • Rapid Assay - Chest Pain Assessment - Product Status
  • Rapid Assay - Chest Pain Assessment - Product Description
  • Rapid Diagnostic Test - Anthrax - Product Status
  • Rapid Diagnostic Test - Anthrax - Product Description
  • LightDeck Diagnostics Inc, Key Employees
  • Glossary
List of Figures
  • LightDeck Diagnostics Inc Pipeline Products by Equipment Type
  • LightDeck Diagnostics Inc Pipeline Products by Development Stage

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Arrayit Diagnostics, Inc.
  • Diamedix Corp
  • Dexall Biomedical Labs Inc